PharmacoEconomics Journal Issues Research Articles in Vol. 41, No. 4
March 17, 2023
March 17, 2023
BASEL, Switzerland, March 17 -- PharmacoEconomics, a peer-reviewed journal that says it features application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes, published research articles on the following topics in its Vol. 41, No. 4 edition:
Review Articles:
* Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
* Co . . .
Review Articles:
* Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
* Co . . .